BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cespedes JC, Liu M, Harbuzariu A, Nti A, Onyekaba J, Cespedes HW, Bharti PK, Solomon W, Anyaoha P, Krishna S, Adjei A, Botchway F, Ford B, Stiles JK. Neuregulin in Health and Disease. Int J Brain Disord Treat 2018;4:024. [PMID: 31032468 DOI: 10.23937/2469-5866/1410024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhai Q, Ren Y, Ni Q, Song Z, Ge K, Guo Y. Transplantation of Human Umbilical Cord Mesenchymal Stem Cells-Derived Neural Stem Cells Pretreated with Neuregulin1β Ameliorate Cerebral Ischemic Reperfusion Injury in Rats. Biomolecules 2022;12:428. [DOI: 10.3390/biom12030428] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Paramo B, Bachmann SO, Baudouin SJ, Martinez-Garay I, Davies AM. Neuregulin-4 Is Required for Maintaining Soma Size of Pyramidal Neurons in the Motor Cortex. eNeuro 2021;8:ENEURO. [PMID: 33495243 DOI: 10.1523/ENEURO.0288-20.2021] [Reference Citation Analysis]
3 Zhao WJ, Ou GY, Lin WW. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas. Front Immunol 2021;12:682415. [PMID: 34054873 DOI: 10.3389/fimmu.2021.682415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ou GY, Lin WW, Zhao WJ. Neuregulins in Neurodegenerative Diseases. Front Aging Neurosci 2021;13:662474. [PMID: 33897409 DOI: 10.3389/fnagi.2021.662474] [Reference Citation Analysis]
5 Qorri B, Tsay M, Agrawal A, Au R, Gracie J. Using machine intelligence to uncover Alzheimer’s disease progression heterogeneity. Exploration of Medicine 2020;1:100126. [DOI: 10.37349/emed.2020.00026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sinevici N, Ataeinia B, Zehnder V, Lin K, Grove L, Heidari P, Mahmood U. HER3 Differentiates Basal From Claudin Type Triple Negative Breast Cancer and Contributes to Drug and Microenvironmental Induced Resistance. Front Oncol 2020;10:554704. [PMID: 33330026 DOI: 10.3389/fonc.2020.554704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]